Radient Technologies Inc. (TSXV:RTI) entered into a letter of intent to acquire PBR Laboratories Inc. for CAD 0.77 million on July 25, 2021. Under the term, Radient Technologies will issue 9 million shares at CAD 0.12 per share. The common shares of Radient issued as consideration for the proposed acquisition are subject to a hold
period of four months following issuance. Post completion, PBR Labs will relocate its current business operations to Radient's laboratory in Edmonton, Alberta. Radient anticipates continuing to use the PBR Labs brand, and PBR Labs will continue its operations as a wholly owned subsidiary of Radient. PBR Labs' president Ram Mehta, has agreed to enter into an executive employment agreement with Radient for a term of no less than two years. Subsequent to the acceptance of the LOI, a due diligence period of no more than 45 business days is to take place, during which both Radient and PBR Labs are entitled to review details of the proposed acquisition and finalize definitive documentation, including a formal share exchange agreement (the "Share Exchange Agreement"), as well as completing tax, accounting, business and legal due diligence. Radient will not be assuming any long-term debt in connection with the acquisition. The transaction is subject to all requisite corporate and regulatory approvals, including approval of TSX Venture Exchange, completion of due diligence and execution share exchange agreement, and other closing conditions customarily found in transactions similar to the proposed acquisition.

Radient Technologies Inc. (TSXV:RTI) cancelled the acquisition of PBR Laboratories Inc. on August 15, 2022. This agreement was terminated on August 15, 2022.